Cadrenal Therapeutics, Inc.
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | |
| 0.28 | 0.42 | 0.59 | 1.17 | 0.71 | 1.01 | 0.90 | 0.55 | 0.34 | 0.33 | 0.32 | 0.24 | 0.97 | |
| 1.03 | 1.04 | 1.05 | 1.14 | 1.52 | 1.80 | 1.22 | 1.35 | 1.00 | 1.20 | 0.72 | 0.90 | 3.03 | |
| 1.32 | 1.46 | 1.64 | 2.31 | 2.23 | 2.81 | 2.13 | 1.90 | 1.34 | 1.54 | 1.04 | 1.15 | 4.00 | |
| -1.32 | -1.46 | -1.64 | -2.31 | -2.23 | -2.81 | -2.13 | -1.90 | -1.34 | -1.54 | -1.04 | -1.15 | -4.00 | |
| 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | – | – | – | – | |
| -1.19 | -1.32 | -1.55 | -2.24 | -2.18 | -2.75 | -2.09 | -1.87 | -1.31 | -1.52 | -1.04 | -1.14 | -3.96 | |
| 0.12 | 0.00 | 0.00 | – | – | – | – | – | – | – | – | – | – | |
| -1.19 | -1.32 | -1.55 | -2.24 | -2.18 | -2.75 | -2.09 | -1.87 | -1.31 | -1.52 | -1.04 | -1.14 | -3.96 | |
| -1.19 | -1.32 | -1.55 | -2.24 | -2.18 | -2.75 | -2.08 | -1.87 | -1.31 | -1.52 | -1.04 | -1.15 | -3.97 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.